Title |
Phase 1b/2a study of galunisertib, a small molecule inhibitor of transforming growth factor-beta receptor I, in combination with standard temozolomide-based radiochemotherapy in patients with newly diagnosed malignant glioma |
|---|---|
Involved |
Antje Wick (Verfasser)
Annick Desjardins (Verfasser) Cristina Suárez García (Verfasser) Peter Forsyth (Verfasser)
Ivelina Gueorguieva (Verfasser)
Tiana Burkholder (Verfasser) Ann Louise Cleverly (Verfasser) Shawn T. Estrem (Verfasser) Shuaicheng Wang (Verfasser) Michael M. Lahn (Verfasser) Susan C. Guba (Verfasser) David Capper (Verfasser) Jordi Rodon (Verfasser) SpringerLink (Online service) (Sonstige) |
Published in |
Investigational new drugs : an interdisciplinary journal for clinicians and scientists 5.3.2020, Seite 1-10 |
Published |
2020 |
Language |
|
Country |
|
Topic |
|
Subject |
Oncology. |
DDC notation |
|
Persistent identifier |
urn:nbn:de:101:1-2020052601032607938024 (URN) |
Record ID |
1210923696 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: